Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||
| Net Income | -20,849 | -19,037 |
| Depreciation Amortization | 2,895 | 2,313 |
| Accounts receivable | 417 | 971 |
| Accounts payable and accrued liabilities | 284 | -349 |
| Other Working Capital | 196 | 521 |
| Other Operating Activity | -333 | 626 |
| Operating Cash Flow | $-17,390 | $-14,955 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 4,497 | -7,498 |
| PPE Investments | -339 | -2,019 |
| Purchase Sale Intangibles | -6,283 | N/A |
| Other Investing Activity | -6,283 | 0 |
| Investing Cash Flow | $-2,125 | $-9,517 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 15,000 | N/A |
| Debt Repayment | -11,671 | -890 |
| Common Stock Issued | 17,350 | 8,523 |
| Other Financing Activity | 232 | 5,500 |
| Financing Cash Flow | $20,911 | $13,133 |
| Beginning Cash Position | 11,947 | 23,286 |
| End Cash Position | 13,343 | 11,947 |
| Net Cash Flow | $1,396 | $-11,339 |
| Free Cash Flow | ||
| Operating Cash Flow | -17,390 | -14,955 |
| Capital Expenditure | -339 | -2,019 |
| Free Cash Flow | -17,729 | -16,974 |